{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:22:14Z","timestamp":1783102934049,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004897","name":"European Organisation for Research and Treatment of Cancer","doi-asserted-by":"publisher","award":["005\\u20132022"],"award-info":[{"award-number":["005\\u20132022"]}],"id":[{"id":"10.13039\/501100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004897","name":"European Organisation for Research and Treatment of Cancer","doi-asserted-by":"publisher","award":["015\/2016"],"award-info":[{"award-number":["015\/2016"]}],"id":[{"id":"10.13039\/501100004897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejca.2026.116774","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:09:10Z","timestamp":1777590550000},"page":"116774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials"],"prefix":"10.1016","volume":"241","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9403-9947","authenticated-orcid":false,"given":"Josien C.C.","family":"Scheepens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2243-7921","authenticated-orcid":false,"given":"Luigi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6228-3531","authenticated-orcid":false,"given":"Jammbe Z.","family":"Musoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil K.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9157-9895","authenticated-orcid":false,"given":"Linda","family":"Dirven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta G.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Bjelic-Radisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corneel","family":"Coens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6047-0098","authenticated-orcid":false,"given":"Jayne","family":"Galinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winette T.A.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-8686","authenticated-orcid":false,"given":"Olga","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampia","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8557-8957","authenticated-orcid":false,"given":"Mary","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-2502","authenticated-orcid":false,"given":"Elke","family":"Rammant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1013-5676","authenticated-orcid":false,"given":"Nazim Serdar","family":"Turhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-632X","authenticated-orcid":false,"given":"Morten Aa.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-780X","authenticated-orcid":false,"given":"Mogens","family":"Gr\u00f8nvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.B.","family":"Taphoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-9616","authenticated-orcid":false,"given":"Johan A.F.","family":"Koekkoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-5950","authenticated-orcid":false,"given":"Johannes M.","family":"Giesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejca.2026.116774_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.ejca.2026.116774_bib2","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1054\/bjoc.2001.2046","article-title":"Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients","volume":"85","author":"Nordin","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.116774_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","article-title":"Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust","volume":"69","author":"Giesinger","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.ejca.2026.116774_bib4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jval.2019.06.004","article-title":"Validation of the European Organisation for research and treatment of cancer quality of life questionnaire core 30 summary score in patients with hematologic malignancies","volume":"22","author":"Efficace","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.ejca.2026.116774_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.116064","article-title":"The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health\/Quality of Life scale: a systematic review and comparative analysis of effect sizes","volume":"231","author":"Scheepens","year":"2025","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116774_bib6","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1038\/s41598-021-84681-0","article-title":"Temporal stability of quality of life assessments in cancer patients","volume":"11","author":"Hinz","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ejca.2026.116774_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jval.2020.10.017","article-title":"Patient-reported outcomes as independent prognostic factors for survival in oncology: systematic review and meta-analysis","volume":"24","author":"Efficace","year":"2021","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.ejca.2026.116774_bib8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","article-title":"The prognostic significance of patient-reported outcomes in cancer clinical trials","volume":"26","author":"Gotay","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2026.116774_bib9","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/S1470-2045(19)30656-4","article-title":"Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review","volume":"20","author":"Mierzynska","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2026.116774_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1477-7525-7-102","article-title":"Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008","volume":"7","author":"Montazeri","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ejca.2026.116774_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103153","article-title":"Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study","volume":"82","author":"Lim","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.ejca.2026.116774_bib12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41416-022-01702-z","article-title":"The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa)","volume":"126","author":"Eichler","year":"2022","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2026.116774_bib13","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1634\/theoncologist.2019-0348","article-title":"The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the \"Real-World\": results from the Population-Based PROFILES Registry","volume":"25","author":"Husson","year":"2020","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.ejca.2026.116774_bib14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10120-021-01209-1","article-title":"Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study","volume":"24","author":"van Kleef","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejca.2026.116774_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2022.03.039","article-title":"Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study","volume":"170","author":"Machingura","year":"2022","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2026.116774_bib16","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S1470-2045(16)30313-8","article-title":"Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study","volume":"17","author":"Baumert","year":"2016","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2026.116774_bib17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2026.116774_bib18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.ejca.2015.04.026","article-title":"Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)","volume":"51","author":"O'Brien","year":"2015","journal-title":"Eur J Cancer"},{"issue":"9829","key":"10.1016\/j.ejca.2026.116774_bib19","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ejca.2026.116774_bib20","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ejca.2026.116774_bib21","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.2015.64.8055","article-title":"Short androgen suppression and radiation dose escalation for intermediate- and high-risk localized prostate cancer: results of EORTC Trial 22991","volume":"34","author":"Bolla","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116774_bib22","series-title":"The EORTC QLQ-C30 Scoring Manual","author":"Fayers","year":"2001"},{"issue":"5","key":"10.1016\/j.ejca.2026.116774_bib23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/jamaoncol.2024.0023","article-title":"Physical activity using a wearable device as an alternative to performance status in patients with advanced lung cancer","volume":"10","author":"Ito","year":"2024","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116774_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","article-title":"Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30","volume":"29","author":"Cocks","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2026.116774_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00439229","article-title":"The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30","volume":"5","author":"King","year":"1996","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.ejca.2026.116774_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2026.116774_bib27","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","article-title":"Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30","volume":"48","author":"Cocks","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116774_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2023.04.027","article-title":"Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: a synthesis across 21 clinical trials involving nine different cancer types","volume":"188","author":"Musoro","year":"2023","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2026.116774_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/sim.4780030207","article-title":"Regression modelling strategies for improved prognostic prediction","volume":"3","author":"Harrell","year":"1984","journal-title":"Stat Med"},{"issue":"16","key":"10.1016\/j.ejca.2026.116774_bib30","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1002\/cncr.31556","article-title":"Quality of life as a prognostic indicator of survival: a pooled analysis of individual patient data from canadian cancer trials group clinical trials","volume":"124","author":"Ediebah","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116774_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2018.11.024","article-title":"General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States","volume":"107","author":"Nolte","year":"2019","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2026.116774_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"9","key":"10.1016\/j.ejca.2026.116774_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials","volume":"10","author":"Quinten","year":"2009","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2026.116774_bib34","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-15-2035","article-title":"Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms","volume":"22","author":"Kluetz","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ejca.2026.116774_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jval.2018.09.2842","article-title":"A review of patient-reported outcomes labeling for oncology drugs approved by the FDA and the EMA (2012-2016)","volume":"22","author":"Gnanasakthy","year":"2019","journal-title":"Value Health"},{"issue":"20","key":"10.1016\/j.ejca.2026.116774_bib36","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.3390\/cancers14205094","article-title":"External validation of the colon life nomogram for predicting 12-week mortality in dutch metastatic colorectal cancer patients treated with trifluridine\/tipiracil in daily practice","volume":"14","author":"Hamers","year":"2022","journal-title":"Cancers"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:01:05Z","timestamp":1783101665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926005551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"alternative-id":["S0959804926005551"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116774","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116774"}}